BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 15364449)

  • 21. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene.
    Chen CH; Wang TL; Hung CF; Yang Y; Young RA; Pardoll DM; Wu TC
    Cancer Res; 2000 Feb; 60(4):1035-42. PubMed ID: 10706121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs.
    Chen CH; Ji H; Suh KW; Choti MA; Pardoll DM; Wu TC
    Gene Ther; 1999 Dec; 6(12):1972-81. PubMed ID: 10637448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine therapy of established tumors in the absence of autoimmunity.
    Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
    Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen.
    Hsu KF; Hung CF; Cheng WF; He L; Slater LA; Ling M; Wu TC
    Gene Ther; 2001 Mar; 8(5):376-83. PubMed ID: 11313814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined immunization with fusion genes of mutated E7 gene of human papillomavirus type 16 did not enhance antitumor effect.
    Pokorná D; Macková J; Dusková M; Rittich S; Ludvíková V; Smahel M
    J Gene Med; 2005 Jun; 7(6):696-707. PubMed ID: 15712328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA vaccines against HPV-16 E7-expressing tumour cells.
    De Marco F; Hallez S; Brulet JM; Gesché F; Marzano P; Flamini S; Marcante ML; Venuti A
    Anticancer Res; 2003; 23(2B):1449-54. PubMed ID: 12820408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
    Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
    Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
    Seo SH; Jin HT; Park SH; Youn JI; Sung YC
    Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The construction and immune response of fusion DNA vaccine CRT180/HPV6E7].
    Zhao KJ; Cheng H; Xu Y; Zhu KJ; Chen ML; Zhang X; Song T; Wang Q; Chen DF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):573-7. PubMed ID: 17718414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secretory heat-shock protein as a dendritic cell-targeting molecule: a new strategy to enhance the potency of genetic vaccines.
    Hauser H; Shen L; Gu QL; Krueger S; Chen SY
    Gene Ther; 2004 Jun; 11(11):924-32. PubMed ID: 15085173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA vaccines employing intracellular targeting strategies and a strategy to prolong dendritic cell life generate a higher number of CD8+ memory T cells and better long-term antitumor effects compared with a DNA prime-vaccinia boost regimen.
    Kim TW; Lee JH; He L; Boyd DA; Hung CF; Wu TC
    Hum Gene Ther; 2005 Jan; 16(1):26-34. PubMed ID: 15703486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of suicidal DNA vaccine potency by delaying suicidal DNA-induced cell death.
    Kim TW; Hung CF; Juang J; He L; Hardwick JM; Wu TC
    Gene Ther; 2004 Feb; 11(3):336-42. PubMed ID: 14737094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination.
    Kim SG; Park MY; Kim CH; Sohn HJ; Kim HS; Park JS; Kim HJ; Oh ST; Kim TG
    Vaccine; 2008 Nov; 26(50):6433-40. PubMed ID: 18812201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant effect of dendritic cells transduced with recombinant vaccinia virus expressing HPV16-E7 is inhibited by co-expression of IL12.
    Mackova J; Kutinova L; Hainz P; Krystofova J; Sroller V; Otahal P; Gabriel P; Nemeckova S
    Int J Oncol; 2004 Jun; 24(6):1581-8. PubMed ID: 15138603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.
    Davidson EJ; Boswell CM; Sehr P; Pawlita M; Tomlinson AE; McVey RJ; Dobson J; Roberts JS; Hickling J; Kitchener HC; Stern PL
    Cancer Res; 2003 Sep; 63(18):6032-41. PubMed ID: 14522932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of an HLA-A*0201 human papillomavirus type 16 tumor model to determine the efficacy of vaccination strategies in HLA-A*0201 transgenic mice.
    Eiben GL; Velders MP; Schreiber H; Cassetti MC; Pullen JK; Smith LR; Kast WM
    Cancer Res; 2002 Oct; 62(20):5792-9. PubMed ID: 12384540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fusion of a tumour-associated antigen to HIV-1 Tat improves protein-based immunotherapy of cancer.
    Giannouli C; Brulet JM; Gesché F; Rappaport J; Burny A; Leo O; Hallez S
    Anticancer Res; 2003; 23(4):3523-31. PubMed ID: 12926102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus.
    Kass E; Schlom J; Thompson J; Guadagni F; Graziano P; Greiner JW
    Cancer Res; 1999 Feb; 59(3):676-83. PubMed ID: 9973217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts.
    Tseng CW; Trimble C; Zeng Q; Monie A; Alvarez RD; Huh WK; Hoory T; Wang MC; Hung CF; Wu TC
    Cancer Immunol Immunother; 2009 May; 58(5):737-48. PubMed ID: 18815785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.